Assoc. Prof. Saygın Abalı is a pediatric endocrinologist with a clinical and academic focus on childhood growth, puberty disorders, diabetes, and hormonal conditions. He completed his specialty training in Pediatric Endocrinology at Marmara University Faculty of Medicine in 2014. Since 2017 he has been affiliated with Acıbadem Health Group, where he provides patient-centered care, coordinates multidisciplinary treatment plans, and participates in clinical education. He is an active member of the Pediatric Endocrinology and Diabetes Association and the Istanbul Medical Chamber. Through these professional memberships he stays current with advances in pediatric endocrine care and contributes to standards of practice and continuing education. Known for clear communication with families and a collaborative approach, he combines evidence-based medicine with empathetic care to support children’s long-term health and development.
Education
- 2014 Marmara University Faculty of Medicine Pediatric Endocrinology
- 2011 Istanbul University Institute of Child Health Pediatrics
- 2005 Dokuz Eylul University Faculty of Medicine
- 1999 Izmir Science High School
Experience
- 2017 Acibadem Health Group
- 2015 – 2017 Kartal Dr. Lütfi Kırdar Training and Research Hospital
- 2011 – 2015 Marmara University Pendik Training and Research Hospital
- 2011 Afyonkarahisar Dinar State Hospital
Memberships
- Pediatric Endocrinology and Diabetes Association
- Istanbul Medical Chamber
- Istanbul Medical Chamber
Publications
- Exome Sequencing of a Primary Ovarian Insufficiency Cohort Reveals Common Molecular Etiologies for a Spectrum of Disease
J Clin Endocrinol Metab. 2019; 104: 3049-3067. Jolly A, Bayram Y, Turan S, Aycan Z, Tos T, Abali ZY, Hacihamdioglu B, Coban Akdemir ZH, Hijazi H, Bas S, Atay Z, Guran T, Abali S, Bas F, - Response to growth hormone treatment in very young patients with growth hormone deficiencies and mini-puberty
J Pediatr Endocrinol Metab. 2018; 31: 175-184. Çetinkaya S, Poyrazoğlu Ş, Baş F, Ercan O, Yıldız M, Adal E, Bereket A, Abalı S, Aycan Z, Erdeve ŞS, Berberoğlu M, Şıklar Z, Tayfun M, Darcan Ş, - The Distribution of Different Types of Diabetes in Childhood: A Single Center Experience
J Clin Res Pediatr Endocrinol. 2018; 10: 125-130. Haliloğlu B, Abalı S, Buğrul F, Çelik E, Baş S, Atay Z, Güran T, Turan S, Bereket A. - Retinal Ganglion Cell Loss in Children With Type 1 Diabetes Mellitus Without Diabetic Retinopathy
Ophthalmic Surg Lasers Imaging Retina. 2017; 48: 473-477. Karti O, Nalbantoglu O, Abali S, Ayhan Z, Tunc S, Kusbeci T, Ozkan B. - CDH3 gene related hypotrichosis and juvenile macular dystrophy – A case with a novel mutation.
Am J Ophthalmol Case Rep. 2017; 7: 129-133. Karti O, Abali S, Ayhan Z, Gokmeydan E, Nalcaci S, Yaman A, Saatci AO. - Hypoglycemia is common in children with cystic fibrosis and seen predominantly in females
Pediatr Diabetes. 2017; 18: 607-613. Haliloglu B, Gokdemir Y, Atay Z, Abali S, Guran T, Karakoc F, Ersu R, Karadag B, Turan S, Bereket A. - GCK gene mutations are a common cause of childhood-onset MODY (maturity-onset diabetes of the young) in Turkey.
Clin Endocrinol (Oxf). 2016; 85: 393-9 Haliloglu B, Hysenaj G, Atay Z, Guran T, Abali S, Turan S, Bereket A, Ellard S. - Risk factors for mortality caused by hypothalamic obesity in children with hypothalamic tumors
Pediatr Obes. 2016; 11: 383-8. Haliloglu B, Atay Z, Guran T, Abali S, Bas S, Turan S, Bereket A. - The Growth Characteristics of Patients with Noonan Syndrome: Results of Three Years of Growth Hormone Treatment: A Nationwide Multicenter Study.
J Clin Res Pediatr Endocrinol. 2016; 8: 305-12. ıklar Z, Genens M, Poyrazoğlu Ş, Baş F, Darendeliler F, Bundak R, Aycan Z, Savaş Erdeve Ş, Çetinkaya S, Güven A, Abalı S, Atay Z, Turan S, Kara C - igher insulin detemir doses are required for the similar glycemic control: comparison of insulin detemir and glargine in children with type 1 diabetes mellitus.
Pediatr Diabetes. 2015; 16: 361-6. Abalı S, Turan S, Atay Z, Güran T, Haliloğlu B, Bereket A.
